Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/28/2025

Rivaroxaban Management for Above Knee Amputation

Preoperative Considerations

  • The American College of Chest Physicians recommends holding rivaroxaban for 2 days (48 hours) before an above knee amputation, with the last dose given 3 days prior to surgery (skipping 2 doses), due to the high-bleeding-risk nature of the procedure 1
  • Above knee amputation is classified as a high-bleeding-risk procedure due to extensive tissue dissection and bone transection, large vascular exposure, significant wound surface area, and prolonged operative time 1, 2

Renal Function Considerations

  • For patients with normal or mildly impaired renal function (CrCl ≥50 mL/min), the American College of Chest Physicians recommends holding rivaroxaban for 2 days before surgery (skip 2 doses), which corresponds to 4-5 drug half-lives (rivaroxaban half-life: 8-9 hours) 2
  • For patients with moderate renal impairment (CrCl 30-50 mL/min), holding rivaroxaban for 3 days before surgery (skip 2 doses) is recommended, due to prolonged drug elimination 2, 3
  • For patients with severe renal impairment (CrCl 15-29.9 mL/min), holding rivaroxaban for 4 days before surgery (skip 3 doses) is recommended, as one-third of rivaroxaban is eliminated renally as unchanged active drug 2, 3

Critical Management Points

  • The American College of Chest Physicians recommends against using bridging anticoagulation, as the rapid offset and onset of rivaroxaban obviate the need for heparin bridging with UFH or LMWH 1, 2
  • Verification of anticoagulation status using prothrombin time (PT) with rivaroxaban-sensitive reagents can confirm low drug levels, although this is not routinely required 2, 4

Postoperative Resumption

  • Rivaroxaban should be resumed 48-72 hours after surgery, once adequate hemostasis is established, with therapeutic anticoagulation achieved within 2-4 hours of rivaroxaban administration 2
  • For high thromboembolic risk patients, a reduced dose (10 mg once daily) for the first 2 days, then full dose (20 mg once daily) may be considered 2